Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04225468 · ClinicalTrials.gov registry record · NA
Safe Options for ACL Recovery
A NA study of Opioid Use and Anterior Cruciate Ligament Injuries, sponsored by Karen Derefinko, PhD.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT04225468: Completed NA study of Opioid Use and Anterior Cruciate Ligament Injuries, sponsored by Karen Derefinko, PhD.
NCT04225468 is a NA study of Opioid Use and Anterior Cruciate Ligament Injuries that has completed, run by Karen Derefinko, PhD. The registered enrollment target is 120 participants, below the 148,259-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04225468, a NA study of Opioid Use and Anterior Cruciate Ligament Injuries, has completed, sponsored by Karen Derefinko, PhD.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the proposed work is to test a brief opioid exposure reduction program (ACL-OERP) designed to improve health literacy about opioid use following surgeries. This intervention is specifically designed to be used with patients (or for patients under 18, the patient and caregiver) undergoing Anterior Cruciate Ligament (ACL) reconstruction, a painful surgery that is often followed by at least 7 days of opioid medication.
Primary Outcome
Cumulative morphine milligram equivalents self-administered following surgery; based upon pill counts
Conditions Studied
Interventions
- BEHAVIORAL ACL Opioid Exposure Reduction Program
Study Locations (1)
Tennessee
- University of Tennessee Health Science Center - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2020-02-12 |
| Est. Completion | 2022-06-03 |
| Phase | NA |
What the finished NCT04225468 record still lists
NCT04225468 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 148,259-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Opioid Use appearing as the primary indexed condition, and to 1 intervention - of which ACL Opioid Exposure Reduction Program is the first listed.
NCT04225468 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT04225468 about?
NCT04225468 is a clinical study titled "Safe Options for ACL Recovery". The purpose of the proposed work is to test a brief opioid exposure reduction program (ACL-OERP) designed to improve health literacy about opioid use following surgeries. This intervention is specifically designed to be used with patients (or for patients under 18, the patient and caregiver) undergo...
What is the current status of trial NCT04225468?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2020-02-12. Estimated completion is 2022-06-03.
What conditions does trial NCT04225468 study?
This clinical trial studies the following conditions: Opioid Use, Anterior Cruciate Ligament Injuries.
What interventions are being tested in trial NCT04225468?
The interventions under investigation include: ACL Opioid Exposure Reduction Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT04225468?
This trial is sponsored by Karen Derefinko, PhD, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04225468 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04225468's enrollment target sits among peer trials
120 58th of 105 higher than 44 of 105 other Opioid Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
QL vs LAI for Palatoplasty
RECRUITING · NA
-
Machine-Learning Prediction and Reducing Overdoses With EHR Nudges
RECRUITING · NA
-
Hip Arthroscopy Postoperative Opioid Demands
RECRUITING · NA
-
Neuroimaging of Opioid Phase (OPAL)
RECRUITING · NA
-
Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives
RECRUITING · NA
-
Opioid Prescribing Practices in Laparoscopic Gynecologic Surgery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI